FDA Places Sun Pharmaceutical on Import Alert Over cGMP Problems

The FDA has added a Sun Pharmaceutical facility in Gujarat, India, to an import alert following an agency inspection, but is exempting 14 products to avoid potential shortages.
Source: Drug Industry Daily